Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

How Risky Is Intuitive Surgical Inc.?

By Keith Speights - Jun 13, 2017 at 8:04AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The maker of the da Vinci robotic surgical system has been soaring, but there are reasons to fear turbulence ahead.

Intuitive Surgical ( ISRG 0.67% ) stock is on a roll so far in 2017. Shares of the robotic surgical system developer are up more than 40% year to date, and recently hit an all-time high.

The obvious question for investors when a stock has been enjoying the kind of tremendous momentum that Intuitive Surgical has recently is: Can it last? The answer depends on the level of risk that's associated with investing in the stock. How risky is Intuitive Surgical right now? 

Businessman pointing with RISK on screen

Image source: Getty Images.

Not too risky?

There's a good case to be made that Intuitive Surgical isn't very risky at all from a business perspective. Demand for its da Vinci robotic surgical systems is growing steadily. In 2016, around 753,000 surgical procedures were performed across the world with da Vinci, up more than 15% from the prior year. In the U.S., general surgery is the system's fastest-growing specialty. This includes hernia repair, colorectal procedures, and gallbladder removal. Outside of the U.S., urology procedures generated the most growth.

Hospitals that buy the da Vinci system have an inherent motivation to maximize the value of their investment. As a result, they perform as many procedures as they can using it. This benefits Intuitive Surgical because the company sells instruments and accessories for the system that either wear out frequently or are disposable. Last year, recurring revenue primarily from these sales accounted for 71% of its total revenue.

The company also stands to benefit from demographic trends. Over the next few years, the two largest U.S. generations -- baby boomers and millennials -- will hit the age ranges in which several of the most common da Vinci-assisted procedures are most likely to be required.

While Intuitive Surgical should be able to count on growing recurring revenue from these factors, it should also be in good position to sell plenty of new systems. Less than 35% of da Vinci surgical systems sold have been installed outside of the U.S., which means a large international market remains for the company to pursue. Intuitive Surgical is also exploring new and more complex types of procedures for da Vinci, which should open the door to additional sales opportunities.

Intuitive Surgical da Vinci system

Image source: Intuitive Surgical.

Very risky?

Investors with a bearish view on Intuitive Surgical would be quick to point out that the company's growth was achieved during a period where there wasn't much competition. That's about to change -- and it could mean that Intuitive Surgical is at more risk than it's ever been before.

Medtronic ( MDT 3.15% ) could be the most formidable rival waiting in the wings. The medical-device company's market cap is more than three times that of Intuitive Surgical, and it expects to launch its own robotic surgical system next year. And the company has inroads with more hospitals across the world than Intuitive Surgical does.

Then there's the potential disruptive innovator, Verb Surgical. It's a joint venture between Google parent Alphabet ( GOOG 0.90% ) ( GOOGL 0.81% ) and healthcare giant Johnson & Johnson ( JNJ 2.23% ). Verb Surgical probably won't have a product on the market until 2020, but when it arrives, it could be a game-changer. The company plans to connect machine learning, robotic surgery, instrumentation, advanced visualization, and data analytics together in a way no other company has attempted.

While competitors could present a business risk to Intuitive Surgical, the hazard to its stock price could be even greater. Intuitive Surgical shares trade at a premium valuation of more than 33 times expected earnings. Its growth prospects are solid, but they don't make the stock look more attractive. Intuitive Surgical's PEG ratio is 3.55 -- a very high level. Given the stock's ambitious valuation, it could take a steep hit if the broader market goes through a correction. 

The best answer

My view is that the best way to assess Intuitive Surgical's risk is to look at the question in terms of short-term risk versus long-term risk. Over the short term, its business seems to be at low risk, thanks to the solid recurring revenue and trends discussed earlier. It's possible that the stock could decline, but smart investors won't be too concerned about temporary pullbacks.

Over the long term, the company does face increased risk as more competitors enter the market. However, my guess at this point is that the risk is only moderate. Intuitive Surgical enjoys a long history in the robotic surgical systems market that should give it a competitive advantage. I expect the company to continue to develop new technologies that will allow it to compete effectively against new rivals.

How risky is Intuitive Surgical? For now, I'd say not too risky. But investors should keep their eyes on Medtronic and Verb Surgical.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Intuitive Surgical, Inc. Stock Quote
Intuitive Surgical, Inc.
$323.77 (0.67%) $2.14
Alphabet Inc. Stock Quote
Alphabet Inc.
$2,863.10 (0.81%) $23.07
Johnson & Johnson Stock Quote
Johnson & Johnson
$162.94 (2.23%) $3.56
Medtronic plc Stock Quote
Medtronic plc
$110.24 (3.15%) $3.37
Alphabet Inc. Stock Quote
Alphabet Inc.
$2,875.93 (0.90%) $25.52

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/07/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.